Double blind placebo control trial of large neutral amino acids in treatment of PKU: effect on blood phenylalanine.
about
Protein substitute for children and adults with phenylketonuriaProtein substitute for children and adults with phenylketonuriaBreakfast with glycomacropeptide compared with amino acids suppresses plasma ghrelin levels in individuals with phenylketonuriaNutritional Management of PhenylketonuriaImproved nutritional management of phenylketonuria by using a diet containing glycomacropeptide compared with amino acidsPhenylketonuria: a review of current and future treatmentsNew Strategies for the Treatment of Phenylketonuria (PKU)Phenylketonuria: translating research into novel therapiesLarge Neutral Amino Acid Supplementation Exerts Its Effect through Three Synergistic Mechanisms: Proof of Principle in Phenylketonuria MiceNovel pharmacological chaperones that correct phenylketonuria in mice.Large neutral amino acids in the treatment of PKU: from theory to practice.Phenylalanine hydroxylase misfolding and pharmacological chaperones.Up to date knowledge on different treatment strategies for phenylketonuria.Inherited Metabolic Disorders: Aspects of Chronic Nutrition Management.Phenylketonuria: nutritional advances and challengesFood products made with glycomacropeptide, a low-phenylalanine whey protein, provide a new alternative to amino Acid-based medical foods for nutrition management of phenylketonuriaNutritional management of PKU with glycomacropeptide from cheese whey.Progress toward cell-directed therapy for phenylketonuria.Long-term treatment of phenylketonuria with a new medical food containing large neutral amino acidsTetrahydrobiopterin, its mode of action on phenylalanine hydroxylase, and importance of genotypes for pharmacological therapy of phenylketonuria.Clinical therapeutics for phenylketonuria.Protein substitutes for phenylketonuria in Europe: access and nutritional composition.Clinical utility gene card for: Phenylketonuria.Oligodendrocyte development and myelinogenesis are not impaired by high concentrations of phenylalanine or its metabolites.The complete European guidelines on phenylketonuria: diagnosis and treatment.Establishing core outcome sets for phenylketonuria (PKU) and medium-chain Acyl-CoA dehydrogenase (MCAD) deficiency in children: study protocol for systematic reviews and Delphi surveys.Effect of Blood Phenylalanine Levels on Oxidative Stress in Classical Phenylketonuric Patients.Dietary intervention in the management of phenylketonuria: current perspectives.Comparison of Glycomacropeptide with Phenylalanine Free-Synthetic Amino Acids in Test Meals to PKU Patients: No Significant Differences in Biomarkers, Including Plasma Phe Levels.
P2860
Q24187935-48BBB400-879C-4CF6-A5B5-80CF9D1F4ABEQ24241445-25DD0ADA-B757-4670-BC61-06CE16848351Q24606705-6CF0BF77-CC08-4EEE-8298-89937A13386BQ24613843-F9E03133-31AD-4D85-9FCA-319A64EB42E4Q24645084-4F7C553C-C167-4EC3-8241-26673B14ED5AQ26770291-0F726794-B473-4755-B6B9-E379D3A44E04Q26999278-0836508D-D2CE-46EB-8B17-180259357C46Q27015749-8214FE16-D1FA-4BAF-A6AD-12F1F6356A4AQ28551217-EF08BC9F-DE07-48C3-AA65-BC4690805BDAQ34127906-3E6DB33F-1267-41CC-8374-D616D94999EAQ34145811-B5348E86-6982-4CB5-BDD0-53F58E497DB1Q34556955-8458238C-26A7-4F73-AD80-B16764A3F16DQ35623929-E0FE9456-386B-426E-877F-BF9FB04EF92BQ35889337-19FA6AB1-72C9-4B88-AD03-45FE6CCFE83FQ36092265-73E82F36-FEFD-4A93-B9DD-DF1121ECC30DQ36110718-636D1511-9FE9-4519-AA80-3AFB28691872Q36786748-BD72E8EF-F997-4BA9-B674-4ADCB96C7D7BQ37170974-326B6D3E-B033-423B-8927-33A515E10802Q37575323-899FFBD1-9372-4215-9597-13ACB9616954Q38096351-FC305207-FDE3-4414-AB42-DE1F2AF3B048Q38383086-09D63799-8E60-4807-9DB1-9652385BC0C1Q39819235-6B6AD1A6-1AB6-4E01-B644-25440841C3FEQ40491970-D56178F8-64FE-43E0-84DE-62CC09DDD380Q42172645-36EAF58A-6AB3-49BB-BEA5-48BF54EE8ED6Q42376686-4680EB78-D6A1-4E92-B8CE-F807AAF501CDQ47281654-30DFC473-E328-4A25-B120-838F90618806Q47559946-0CF6CF13-6474-4D65-9E22-76B988F80336Q49500552-C730AA79-9D1E-4417-8B99-91D23FE851A7Q55386185-1DD4EAFE-BFD5-495D-9D46-45ECFEC10C85
P2860
Double blind placebo control trial of large neutral amino acids in treatment of PKU: effect on blood phenylalanine.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Double blind placebo control t ...... effect on blood phenylalanine.
@en
Double blind placebo control t ...... effect on blood phenylalanine.
@nl
type
label
Double blind placebo control t ...... effect on blood phenylalanine.
@en
Double blind placebo control t ...... effect on blood phenylalanine.
@nl
prefLabel
Double blind placebo control t ...... effect on blood phenylalanine.
@en
Double blind placebo control t ...... effect on blood phenylalanine.
@nl
P2093
P1476
Double blind placebo control t ...... effect on blood phenylalanine.
@en
P2093
A B Burlina
A P Burlina
E Grechanina
K Michals-Matalon
M Giovannini
P2888
P304
P356
10.1007/S10545-007-0556-4
P577
2007-02-27T00:00:00Z
P6179
1002736870